54 results match your criteria: "and Bioethics at Harvard Law School.[Affiliation]"

Declining U.S. Fertility and Births Rates: A Shrinking Nation.

J Womens Health (Larchmt)

December 2024

Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard University, Cambridge, Massachusetts, USA.

View Article and Find Full Text PDF

Policy Points The reinstitution of pre-COVID-19 pandemic licensure regulations has impeded interstate telehealth. This has disproportionately impacted patients who live near a state border; geographically mobile patients, such as college students; and patients with rare diseases who may need care from a specialist outside their state. Several promising and feasible reforms are available, at both state and federal levels, to facilitate interstate telehealth.

View Article and Find Full Text PDF

Artificial intelligence (AI)-enabled chatbots are increasingly being used to help people manage their mental health. Chatbots for mental health and particularly 'wellness' applications currently exist in a regulatory 'gray area'. Indeed, most generative AI-powered wellness apps will not be reviewed by health regulators.

View Article and Find Full Text PDF

The Pregnant Workers Fairness Act-a Bipartisan Step Forward.

JAMA Health Forum

February 2024

Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard University, Cambridge, Massachusetts.

View Article and Find Full Text PDF

The Legal Determinants of Scarcity: Expanding Human Rights Advocacy for Affordability of Health Technologies.

Health Hum Rights

December 2023

Lecturer in human rights at the Helena Kennedy Center for International Justice, Sheffield Hallam University, UK, and an affiliated researcher at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, United States.

Recognizing law as a determinant of scarcity in health care is vital. This paper underscores the need for a comprehensive approach to manage scarcity beyond intellectual property, using targeted regulations to promote affordability and counter market distortions. I argue that relying on law solely to ensure democratic deliberations for resource allocation overlooks market failures and economic inequalities that contribute to scarcity.

View Article and Find Full Text PDF

Climate Change and Economic Inequality: Are We Responding to Health Injustices?

Health Hum Rights

December 2023

Postdoctoral researcher at Tilburg Law School, Tilburg University, the Netherlands and Project Affiliated Researcher of the Global Health and Human Rights Project at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, USA.

View Article and Find Full Text PDF

State-Regulated Psychedelics on a Collision Course With FDA.

JAMA

December 2023

Project on Psychedelics Law and Regulation (POPLAR), Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, Massachusetts.

View Article and Find Full Text PDF

novel forms of assisted gestation, legal challenges, and perspectives of reproductive rights advocates in England and Wales.

J Law Biosci

November 2023

Centre for Ethics and Law in the Life Sciences, Durham Law School, Durham University, Durham, United Kingdom.

A growing body of literature examines the ethico-legal challenges resulting from novel forms of assisted gestation like uterus transplantation and artificial placentas (also known as 'artificial wombs'). However, there has not yet been consideration of reproductive rights organizations/advocates' understandings of novel forms of assisted gestation and their challenges. These perspectives provide critical insight into how novel procreative practices are understood and the problems and pressures that might arise from their use.

View Article and Find Full Text PDF

How Should the FDA Evaluate Psychedelic Medicine?

N Engl J Med

November 2023

From the Project on Psychedelics Law and Regulation, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School (M.M., I.G.C.), and Harvard Law School (I.G.C.) - both in Cambridge, MA; and Florida State University College of Law, Tallahassee (M.M.).

View Article and Find Full Text PDF

The relationship between speculation and translation in Bioethics: methods and methodologies.

Monash Bioeth Rev

December 2023

Centre for Ethics and Law in the Life Sciences, Durham Law School, University of Durham, Durham, UK.

There are increasing pressures for bioethics to emphasise 'translation'. Against this backdrop, we defend 'speculative bioethics'. We explore speculation as an important tool and line of bioethical inquiry.

View Article and Find Full Text PDF

Rules are needed for human research in commercial spaceflight.

View Article and Find Full Text PDF

While the literature on putting a "human in the loop" in artificial intelligence (AI) and machine learning (ML) has grown significantly, limited attention has been paid to how human expertise ought to be combined with AI/ML judgments. This design question arises because of the ubiquity and quantity of algorithmic decisions being made today in the face of widespread public reluctance to forgo human expert judgment. To resolve this conflict, we propose that human expert judges be included via appeals processes for review of algorithmic decisions.

View Article and Find Full Text PDF

After considerable progress in recent decades, maternal mortality and morbidity (MMM) either stagnated or worsened in most regions of the globe between 2016 and 2020. The world should be outraged given that we have known the key interventions necessary for preventing MMM for over three-quarters of a century. Since the 1990s, human rights advocacy on MMM has gained crucial ground, demonstrating that entitlements related to maternal health are judicially enforceable and delineating rights-based approaches to health in the context of MMM.

View Article and Find Full Text PDF

Novel forms of assisted gestation-uterus transplantation and artificial placentas-are highly anticipated in the ethico-legal literature for their capacity to enhance reproductive autonomy. There are also, however, significant challenges anticipated in the development of novel forms of assisted gestation. While there is a normative exploration of these challenges in the literature, there has not yet, to my knowledge, been empirical research undertaken to explore what reproductive rights organisations and advocates identify as potential benefits and challenges.

View Article and Find Full Text PDF

The HeLa cell line was created in 1951 without consent from Henrietta Lacks, the person whose tissue sample was used. In 2021, the descendants of Henrietta Lacks sued a well-known biotechnology company for the profits it made from the HeLa cell line. In this article, ownership of the cell lines is investigated from a South African legal perspective by considering three possible contemporary scenarios bearing points of similarity to the Henrietta Lacks case.

View Article and Find Full Text PDF

The Inflation Reduction Act: Recasting the Medicare Prescription Drug Plans.

Am J Prev Med

June 2023

Harvard Law School, Harvard University, Cambridge, Massachusetts; Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard University, Cambridge, Massachusetts.

View Article and Find Full Text PDF

Drug scheduling limits access to essential medicines and should be reformed.

Nat Med

February 2023

Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, MA, USA.

View Article and Find Full Text PDF

Background: Telemedical early medical abortion (TEMA) was introduced in England and Wales as a temporary measure in 2020 and was made permanent in 2022. While there are considerable data showing the safety, efficacy, and acceptability of TEMA for patients, there have been objections raised to TEMA based on safeguarding-particularly for people under 18 years of age. Little is known about abortion care providers' views and experiences of carrying out their safeguarding duties with people aged under 18 in the shift to TEMA.

View Article and Find Full Text PDF

Abortion Access and the Benefits and Limitations of Abortion- Legal Frameworks: Lessons from the United Kingdom.

Camb Q Healthc Ethics

July 2023

Centre for Ethics and Law in the Life Sciences, Durham Law School, Durham University, Durham, UK.

This paper argues that abortion access is an important subject for bioethics scholarship and reflects on the relationship between legal frameworks and access to care. The author uses the example of the United Kingdom to examine the benefits and limitations of abortion- legal frameworks in terms of access. These are legal frameworks that enable the provision of abortion but subject to restrictions.

View Article and Find Full Text PDF

The varieties of psychedelic law.

Neuropharmacology

March 2023

Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, 23 Everett St, 3rd Floor, Cambridge, MA, 02138, USA; Florida State University College of Law, 301 S Martin Luther King Jr Blvd, Tallahassee, FL, 32301, USA. Electronic address:

After decades of prohibition, psychedelics are generating intense public and private interest. Scientists are researching the therapeutic properties of these substances, and mounting evidence supports their ability to treat a variety of mental health conditions. Meanwhile, dozens of cities and states are proposing or enacting psychedelics legislation to promote research, increase therapeutic and non-therapeutic access, and decrease criminal penalties associated with producing, possessing, or consuming psychedelics.

View Article and Find Full Text PDF